CHI3L1 and breast cancer: suggested that CAFs promote immunosuppressive and pro-inflammatory microenvironment in breast cancer by secreting Chitinase 3-like 1 (Chi3L1), a glycoprotein that has been associated with poor survival and prognosis in breast cancer patients.